Analysts Set Lam Research Corporation (NASDAQ:LRCX) PT at $148.54

Shares of Lam Research Corporation (NASDAQ:LRCX) have been given a consensus recommendation of “Moderate Buy” by the thirty-six analysts that are presently covering the stock, Marketbeat reports. Nine analysts have rated the stock with a hold recommendation, twenty-six have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $149.04.

Several research analysts have weighed in on LRCX shares. UBS Group set a $165.00 price target on Lam Research and gave the company a “buy” rating in a report on Thursday, October 23rd. Summit Insights downgraded Lam Research from a “buy” rating to a “hold” rating in a research report on Thursday, July 31st. Wall Street Zen lowered Lam Research from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. New Street Research increased their target price on Lam Research from $105.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Finally, Rothschild & Co Redburn lifted their price target on Lam Research from $140.00 to $150.00 and gave the company a “buy” rating in a report on Tuesday, October 14th.

Insider Activity at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 62,528 shares of company stock worth $8,880,448. 0.31% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LRCX. IMG Wealth Management Inc. purchased a new position in shares of Lam Research in the 2nd quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research during the 2nd quarter worth approximately $27,000. Strategic Wealth Investment Group LLC acquired a new stake in Lam Research during the 2nd quarter worth approximately $29,000. Delos Wealth Advisors LLC purchased a new position in Lam Research in the second quarter valued at approximately $30,000. Finally, REAP Financial Group LLC acquired a new position in Lam Research during the second quarter valued at approximately $31,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Price Performance

NASDAQ:LRCX opened at $148.26 on Wednesday. Lam Research has a 12-month low of $56.32 and a 12-month high of $167.15. The firm has a market cap of $186.22 billion, a price-to-earnings ratio of 32.66, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The company’s 50-day moving average is $140.75 and its two-hundred day moving average is $109.40. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue was up 27.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Research analysts expect that Lam Research will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.